Synchron Inc. is a leader in the implantable brain-computer-interface (BCI) space. Based in Brooklyn, New York, Synchron is conducting human clinical studies for their proprietary product.
Aurenar is creating a unique, disposable, wearable neuromodulation device that is changing the arc of care of critically ill patients.
Fluid Biomed is commercializing the first polymer-based brain stent to cure aneurysms. Brain aneurysms afflict up to 5% of people and can lead to devastating stroke. The company team of neurosurgeons, scientists, and engineers has designed the world’s first hybrid polymer-metal flow-diverting stent to cure this deadly disease.
Creating a bridge between humans and machines for the enhancement of people’s lives.
Comprehensive virtual care for people who have experienced a stroke. Precision Recovery is helping patients feel safe, connected and in control of their recovery from the comfort of their home.
Proprio is a technology company modernizing the way we predict, perform, and perfect surgery through the combination of physician expertise and immersive, intelligent technology.
A breakthrough technology to directly restore shoulder, arm, and hand movement for stroke survivors.
Synchron Inc. is a leader in the minimally invasive implantable brain-computer-interface (BCI) space. Based in Palo Alto, California, Synchron is conducting the first BCI in-human trials approved in the US for their proprietary product
Von Vascular, Inc. is at the forefront of medical device innovation, dedicated to transforming thrombectomy with groundbreaking technologies.
